Logo image of VYX

NCR VOYIX CORP (VYX) Stock Fundamental Analysis

NYSE:VYX - New York Stock Exchange, Inc. - US62886E1082 - Common Stock - Currency: USD

14.195  -0.44 (-2.97%)

Fundamental Rating

3

Taking everything into account, VYX scores 3 out of 10 in our fundamental rating. VYX was compared to 282 industry peers in the Software industry. VYX has a medium profitability rating, but doesn't score so well on its financial health evaluation. VYX has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

5

1. Profitability

1.1 Basic Checks

In the past year VYX was profitable.
VYX had a negative operating cash flow in the past year.
In multiple years VYX reported negative net income over the last 5 years.
Of the past 5 years VYX 4 years had a positive operating cash flow.
VYX Yearly Net Income VS EBIT VS OCF VS FCFVYX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B

1.2 Ratios

With an excellent Return On Assets value of 21.26%, VYX belongs to the best of the industry, outperforming 95.74% of the companies in the same industry.
Looking at the Return On Equity, with a value of 81.38%, VYX belongs to the top of the industry, outperforming 97.52% of the companies in the same industry.
With a decent Return On Invested Capital value of 1.21%, VYX is doing good in the industry, outperforming 65.96% of the companies in the same industry.
Industry RankSector Rank
ROA 21.26%
ROE 81.38%
ROIC 1.21%
ROA(3y)4.26%
ROA(5y)2.43%
ROE(3y)-21.78%
ROE(5y)-13.67%
ROIC(3y)N/A
ROIC(5y)N/A
VYX Yearly ROA, ROE, ROICVYX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100

1.3 Margins

VYX has a Profit Margin of 26.78%. This is amongst the best in the industry. VYX outperforms 92.91% of its industry peers.
VYX's Profit Margin has improved in the last couple of years.
Looking at the Operating Margin, with a value of 1.31%, VYX is in the better half of the industry, outperforming 64.54% of the companies in the same industry.
In the last couple of years the Operating Margin of VYX has declined.
VYX's Gross Margin of 20.74% is on the low side compared to the rest of the industry. VYX is outperformed by 81.91% of its industry peers.
In the last couple of years the Gross Margin of VYX has declined.
Industry RankSector Rank
OM 1.31%
PM (TTM) 26.78%
GM 20.74%
OM growth 3Y-43.61%
OM growth 5Y-31.2%
PM growth 3Y208.92%
PM growth 5Y38.43%
GM growth 3Y-8.16%
GM growth 5Y-5.91%
VYX Yearly Profit, Operating, Gross MarginsVYX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 30

More info and screens

2

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), VYX is destroying value.
The number of shares outstanding for VYX has been reduced compared to 1 year ago.
Compared to 5 years ago, VYX has more shares outstanding
Compared to 1 year ago, VYX has an improved debt to assets ratio.
VYX Yearly Shares OutstandingVYX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M
VYX Yearly Total Debt VS Total AssetsVYX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.2 Solvency

Based on the Altman-Z score of 1.41, we must say that VYX is in the distress zone and has some risk of bankruptcy.
VYX has a Altman-Z score (1.41) which is in line with its industry peers.
A Debt/Equity ratio of 0.97 indicates that VYX is somewhat dependend on debt financing.
VYX has a Debt to Equity ratio of 0.97. This is in the lower half of the industry: VYX underperforms 72.34% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.97
Debt/FCF N/A
Altman-Z 1.41
ROIC/WACC0.11
WACC11.23%
VYX Yearly LT Debt VS Equity VS FCFVYX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B 4B 5B

2.3 Liquidity

VYX has a Current Ratio of 1.12. This is a normal value and indicates that VYX is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.12, VYX is doing worse than 68.44% of the companies in the same industry.
VYX has a Quick Ratio of 1.12. This is a bad value and indicates that VYX is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.96, VYX is not doing good in the industry: 75.18% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.12
Quick Ratio 0.96
VYX Yearly Current Assets VS Current LiabilitesVYX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

More info and screens

3

3. Growth

3.1 Past

The earnings per share for VYX have decreased strongly by -66.67% in the last year.
The earnings per share for VYX have been decreasing by -31.03% on average. This is quite bad
VYX shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -60.40%.
VYX shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -16.39% yearly.
EPS 1Y (TTM)-66.67%
EPS 3Y-44.54%
EPS 5Y-31.03%
EPS Q2Q%-30.77%
Revenue 1Y (TTM)-60.4%
Revenue growth 3Y-26.63%
Revenue growth 5Y-16.39%
Sales Q2Q%-28.42%

3.2 Future

Based on estimates for the next years, VYX will show a very strong growth in Earnings Per Share. The EPS will grow by 34.08% on average per year.
Based on estimates for the next years, VYX will show a decrease in Revenue. The Revenue will decrease by -9.14% on average per year.
EPS Next Y79.05%
EPS Next 2Y49%
EPS Next 3Y34.08%
EPS Next 5YN/A
Revenue Next Year-9.04%
Revenue Next 2Y-11.79%
Revenue Next 3Y-9.14%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
VYX Yearly Revenue VS EstimatesVYX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2B 4B 6B
VYX Yearly EPS VS EstimatesVYX Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 1 2 3

More info and screens

5

4. Valuation

4.1 Price/Earnings Ratio

VYX is valuated quite expensively with a Price/Earnings ratio of 35.49.
Compared to the rest of the industry, the Price/Earnings ratio of VYX indicates a somewhat cheap valuation: VYX is cheaper than 67.38% of the companies listed in the same industry.
When comparing the Price/Earnings ratio of VYX to the average of the S&P500 Index (27.69), we can say VYX is valued slightly more expensively.
The Price/Forward Earnings ratio is 14.53, which indicates a correct valuation of VYX.
Compared to the rest of the industry, the Price/Forward Earnings ratio of VYX indicates a rather cheap valuation: VYX is cheaper than 86.52% of the companies listed in the same industry.
VYX's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 37.36.
Industry RankSector Rank
PE 35.49
Fwd PE 14.53
VYX Price Earnings VS Forward Price EarningsVYX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of VYX indicates a rather cheap valuation: VYX is cheaper than 95.39% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 7.92
VYX Per share dataVYX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20

4.3 Compensation for Growth

VYX's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
VYX's earnings are expected to grow with 34.08% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.45
PEG (5Y)N/A
EPS Next 2Y49%
EPS Next 3Y34.08%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for VYX!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

NCR VOYIX CORP

NYSE:VYX (7/24/2025, 3:59:03 PM)

14.195

-0.44 (-2.97%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)05-08 2025-05-08/bmo
Earnings (Next)08-05 2025-08-05
Inst Owners113.37%
Inst Owner ChangeN/A
Ins Owners0.37%
Ins Owner Change21.09%
Market Cap1.96B
Analysts85
Price Target15.56 (9.62%)
Short Float %13.82%
Short Ratio10.45
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.11
Dividend Growth(5Y)N/A
DP1.63%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)147.53%
Min EPS beat(2)55.59%
Max EPS beat(2)239.46%
EPS beat(4)3
Avg EPS beat(4)87.32%
Min EPS beat(4)-45.76%
Max EPS beat(4)239.46%
EPS beat(8)5
Avg EPS beat(8)35.38%
EPS beat(12)8
Avg EPS beat(12)25.97%
EPS beat(16)10
Avg EPS beat(16)17.12%
Revenue beat(2)1
Avg Revenue beat(2)-0.36%
Min Revenue beat(2)-1.67%
Max Revenue beat(2)0.95%
Revenue beat(4)2
Avg Revenue beat(4)-4.57%
Min Revenue beat(4)-19.37%
Max Revenue beat(4)1.8%
Revenue beat(8)3
Avg Revenue beat(8)10.83%
Revenue beat(12)5
Avg Revenue beat(12)7.13%
Revenue beat(16)6
Avg Revenue beat(16)4.63%
PT rev (1m)7.02%
PT rev (3m)-3.94%
EPS NQ rev (1m)-1.89%
EPS NQ rev (3m)-10.38%
EPS NY rev (1m)0.43%
EPS NY rev (3m)9.09%
Revenue NQ rev (1m)-0.16%
Revenue NQ rev (3m)-0.58%
Revenue NY rev (1m)-0.04%
Revenue NY rev (3m)2.74%
Valuation
Industry RankSector Rank
PE 35.49
Fwd PE 14.53
P/S 0.57
P/FCF N/A
P/OCF N/A
P/B 1.73
P/tB N/A
EV/EBITDA 7.92
EPS(TTM)0.4
EY2.82%
EPS(NY)0.98
Fwd EY6.88%
FCF(TTM)-2.42
FCFYN/A
OCF(TTM)-1.01
OCFYN/A
SpS24.99
BVpS8.23
TBVpS-3.45
PEG (NY)0.45
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 21.26%
ROE 81.38%
ROCE 1.54%
ROIC 1.21%
ROICexc 1.51%
ROICexgc 4.75%
OM 1.31%
PM (TTM) 26.78%
GM 20.74%
FCFM N/A
ROA(3y)4.26%
ROA(5y)2.43%
ROE(3y)-21.78%
ROE(5y)-13.67%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y-36.27%
ROICexcg growth 5Y-25.75%
ROICexc growth 3Y-36.4%
ROICexc growth 5Y-30.51%
OM growth 3Y-43.61%
OM growth 5Y-31.2%
PM growth 3Y208.92%
PM growth 5Y38.43%
GM growth 3Y-8.16%
GM growth 5Y-5.91%
F-Score5
Asset Turnover0.79
Health
Industry RankSector Rank
Debt/Equity 0.97
Debt/FCF N/A
Debt/EBITDA 3.42
Cap/Depr 70.65%
Cap/Sales 5.66%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.12
Quick Ratio 0.96
Altman-Z 1.41
F-Score5
WACC11.23%
ROIC/WACC0.11
Cap/Depr(3y)67.44%
Cap/Depr(5y)68.37%
Cap/Sales(3y)8.12%
Cap/Sales(5y)6.69%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-66.67%
EPS 3Y-44.54%
EPS 5Y-31.03%
EPS Q2Q%-30.77%
EPS Next Y79.05%
EPS Next 2Y49%
EPS Next 3Y34.08%
EPS Next 5YN/A
Revenue 1Y (TTM)-60.4%
Revenue growth 3Y-26.63%
Revenue growth 5Y-16.39%
Sales Q2Q%-28.42%
Revenue Next Year-9.04%
Revenue Next 2Y-11.79%
Revenue Next 3Y-9.14%
Revenue Next 5YN/A
EBIT growth 1Y-93.3%
EBIT growth 3Y-58.63%
EBIT growth 5Y-42.48%
EBIT Next Year376.67%
EBIT Next 3Y74.29%
EBIT Next 5Y46.94%
FCF growth 1Y-203.09%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-119.74%
OCF growth 3YN/A
OCF growth 5YN/A